Phio Pharmaceuticals (PHIO) News Today $1.76 +0.02 (+1.15%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)October 24, 2024 | theglobeandmail.comPhio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer ConferenceOctober 1, 2024 | finance.yahoo.comUS says navy aeroplane transits Taiwan StraitSeptember 17, 2024 | msn.comPhio Pharmaceuticals Corp. (PHIO)September 15, 2024 | finance.yahoo.comPhio Pharmaceuticals Corp.: Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow SeriesAugust 29, 2024 | finanznachrichten.dePhio Pharmaceuticals Corp.'s (NASDAQ:PHIO) Path To ProfitabilityAugust 27, 2024 | finance.yahoo.comPhio Pharmaceuticals CorpAugust 21, 2024 | morningstar.comPhio Pharmaceuticals appoints new CFOAugust 3, 2024 | uk.investing.comPhio Pharmaceuticals secures investment from TRITON FundsMay 19, 2024 | investing.comPhio Pharmaceuticals Corp.: Phio Pharmaceuticals Secures New InvestorMay 17, 2024 | finanznachrichten.dePhio Pharmaceuticals Secures New InvestorMay 17, 2024 | globenewswire.comPhio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID)May 16, 2024 | finance.yahoo.comPhio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation StudyMay 15, 2024 | globenewswire.comBuy Rating Affirmed for Phio Pharmaceuticals Amid Promising INTASYL Technology and PH-762 Clinical ProgressMay 15, 2024 | markets.businessinsider.comPhio Pharmaceuticals Corp.: Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business UpdateMay 10, 2024 | finanznachrichten.dePhio Pharmaceuticals Reports Q1 2024 Results and Provides Business UpdateMay 9, 2024 | globenewswire.comPhio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)April 30, 2024 | globenewswire.comPhio Pharmaceuticals reports progress on cancer therapy PH-762April 24, 2024 | investing.comWhy Is Penny Stock Phio Pharmaceuticals Trading Higher On Monday?April 22, 2024 | benzinga.comIntratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cellsApril 22, 2024 | finance.yahoo.comIntratumoral Injection of Phio's PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cellsApril 22, 2024 | globenewswire.comPhio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)April 16, 2024 | globenewswire.comPhio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)April 11, 2024 | globenewswire.comNational Spotlight Features Phio’s Innovative RNAi Technology PlatformApril 3, 2024 | finance.yahoo.comNational Spotlight Features Phio's Innovative RNAi Technology PlatformApril 3, 2024 | globenewswire.comPhio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business UpdateApril 2, 2024 | globenewswire.comPhio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological MalignanciesMarch 21, 2024 | finance.yahoo.comPhio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity ResearchMarch 13, 2024 | globenewswire.comPhio Pharmaceuticals Corp PHIOMarch 10, 2024 | morningstar.comAnalysts Are Bullish on These Healthcare Stocks: Neurogene (NGNE), Akero Therapeutics (AKRO)March 6, 2024 | markets.businessinsider.comPhio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin DisordersMarch 6, 2024 | finance.yahoo.comPhio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company's Intellectual Property Position in Treating Aging Skin and Skin DisordersMarch 6, 2024 | globenewswire.comDry Age Related Macular Degeneration Market Report 2024: Global Trends, Forecasts and Competitive Analysis 2018-2023 and 2024-2030February 14, 2024 | uk.finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and Phio Pharmaceuticals (PHIO)February 6, 2024 | markets.businessinsider.comPhio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological MalignanciesJanuary 31, 2024 | finance.yahoo.comPhio Pharmaceuticals files to sell 4.42M shares of common stock for holdersDecember 19, 2023 | msn.comWhy Phio Pharmaceuticals Stock Is NosedivingDecember 7, 2023 | msn.comPhio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross ProceedsDecember 7, 2023 | finance.yahoo.comPhio Pharmaceuticals Corp.: Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 10, 2023 | finanznachrichten.dePhio Pharmaceuticals GAAP EPS of -$1.14 beats by $0.29November 10, 2023 | msn.comPhio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 9, 2023 | finance.yahoo.comPhio Pharmaceuticals Announces First US Patient Enrolled in Phase 1B Clinical Trial with Intratumoral PH-762 anti-PD-1 Therapy for Treatment of Skin CarcinomasNovember 9, 2023 | finance.yahoo.comPhio Pharmaceuticals Corp.: Phio Pharmaceuticals Presents New Data Showing INTASYL Compound targeting CTLA-4 Enhances Tumor ControlNovember 3, 2023 | finanznachrichten.dePhio Pharmaceuticals Presents New Data Showing INTASYL Compound targeting CTLA-4 Enhances Tumor ControlNovember 3, 2023 | finance.yahoo.comPhio Pharmaceuticals Announces Upcoming Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)October 12, 2023 | finance.yahoo.comPHIO Jumps 91% on Encouraging Preclinical Cancer Drug DataOctober 12, 2023 | finance.yahoo.comPhio Pharmaceuticals Shares Up 60% on Favorable PH-894 Preclinical DataOctober 11, 2023 | marketwatch.comCrude Oil Down 2.5%; Silk Road Medical Shares PlummetOctober 11, 2023 | markets.businessinsider.comPhio Pharmaceuticals, Exscientia among healthcare moversOctober 11, 2023 | msn.comWhy Is Immuno-Oncology Focused Phio Pharmaceuticals Stock Trading Higher Today?October 11, 2023 | benzinga.com Get Phio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PHIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover PHIO Media Mentions By Week PHIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHIO News Sentiment▼0.000.60▲Average Medical News Sentiment PHIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHIO Articles This Week▼00▲PHIO Articles Average Week Get Phio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PHIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AWH News Today CRVO News Today RLMD News Today TLPH News Today KZIA News Today KPRX News Today TSBX News Today SNSE News Today JAGX News Today PHXM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHIO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phio Pharmaceuticals Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
